Literature DB >> 33155834

Risk Factors for Mortality in 220 Patients With COVID-19 in Wuhan, China: A Single-Center, Retrospective Study.

Shuliang Zhou1, Sulin Mi2, Shuilian Luo2, Ying Wang3, Bin Ren4, Lin Cai4, Meng Wu2.   

Abstract

BACKGROUND: An outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 infection occurred in Wuhan, China, in December 2019. To date, the analysis of fatal cases and the risk factors for death have rarely been reported.
METHODS: In this study, 220 adult patients with confirmed and suspected COVID-19 were enrolled. Clinical characteristics, laboratory data, treatments, and complications were compared between 168 survivors and 52 nonsurvivors. Univariable analysis and multivariable logistic regression were used to investigate the risk factors for mortality.
RESULTS: A total of 220 patients (168 were discharged and 52 died in the hospital) were enrolled in the study. The median age of all patients was 59.5 (47.0-69.0) years, and the median age of patients who died was significantly older than that of patients who survived (70.5 vs 56.0 years, respectively; P < .001). According to multivariate logistic regression, older age (odds ratio: 1.09, 95% CI: 1.03-1.15; P = .001), initial Sequential Organ Failure Assessment (SOFA) score >2 (37.4, 9.4-148.0; P = .011), and respiratory rate >24 per minute (10.89, 1.47-80.67; P = .019) were independent risk factors for mortality.
CONCLUSION: Clinical and laboratory parameters predicting poor prognosis including older age, baseline SOFA score >2, and respiratory rate >24 per minute were identified.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; Wuhan; risk factors for mortality

Mesh:

Substances:

Year:  2020        PMID: 33155834     DOI: 10.1177/0145561320972608

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  6 in total

Review 1.  Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Abraham Degarege; Zaeema Naveed; Josiane Kabayundo; David Brett-Major
Journal:  Pathogens       Date:  2022-05-10

2.  Cardiac biomarkers and COVID-19: A systematic review and meta-analysis.

Authors:  Wen An; Ju-Seop Kang; Qiuyang Wang; Tae-Eun Kim
Journal:  J Infect Public Health       Date:  2021-07-29       Impact factor: 7.537

3.  Effect of convalescent plasma therapy on mortality in moderate-to-severely Ill COVID-19 patients.

Authors:  Akanksha Agrawal; Tanvi Jha; Priyanka Gogoi; Preeti Diwaker; Ashish Goel; Amir Maroof Khan; Ashok Kumar Saxena
Journal:  Transfus Apher Sci       Date:  2022-05-11       Impact factor: 2.596

4.  Admission vital signs as predictors of COVID-19 mortality: a retrospective cross-sectional study.

Authors:  Ahmed Sameer Ikram; Somasundram Pillay
Journal:  BMC Emerg Med       Date:  2022-04-29

5.  Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients.

Authors:  Ganesh Korishettar; Prashanth Chikkahonnaiah; SubbaRao V Tulimilli; Siva Dallavalasa; Shashidhar H Byrappa; SubbaRao V Madhunapantula; Ravindra P Veeranna
Journal:  Vaccines (Basel)       Date:  2022-07-15

6.  Assessing the Nationwide COVID-19 Risk in Mexico through the Lens of Comorbidity by an XGBoost-Based Logistic Regression Model.

Authors:  Sonia Venancio-Guzmán; Alejandro Ivan Aguirre-Salado; Carlos Soubervielle-Montalvo; José Del Carmen Jiménez-Hernández
Journal:  Int J Environ Res Public Health       Date:  2022-09-22       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.